Suppr超能文献

基于特征加权分子谱的泛癌症细胞系肿瘤相似性研究

A pan-cancer survey of cell line tumor similarity by feature-weighted molecular profiles.

机构信息

Department of Genetics and Genomic Sciences, Icahn Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

出版信息

Cell Rep Methods. 2021 Jun 21;1(2):100039. doi: 10.1016/j.crmeth.2021.100039.

Abstract

Patient-derived cell lines are often used in pre-clinical cancer research, but some cell lines are too different from tumors to be good models. Comparison of genomic and expression profiles can guide the choice of pre-clinical models, but typically not all features are equally relevant. We present TumorComparer, a computational method for comparing cellular profiles with higher weights on functional features of interest. In this pan-cancer application, we compare ∼600 cell lines and ∼8,000 tumor samples of 24 cancer types, using weights to emphasize known oncogenic alterations. We characterize the similarity of cell lines and tumors within and across cancers by using multiple datum types and rank cell lines by their inferred quality as representative models. Beyond the assessment of cell lines, the weighted similarity approach is adaptable to patient stratification in clinical trials and personalized medicine.

摘要

患者来源的细胞系常用于临床前癌症研究,但有些细胞系与肿瘤差异太大,不能作为良好的模型。基因组和表达谱的比较可以指导临床前模型的选择,但通常并非所有特征都同等相关。我们提出了 TumorComparer,这是一种用于比较细胞谱的计算方法,对感兴趣的功能特征赋予更高的权重。在这项泛癌应用中,我们比较了 24 种癌症类型的约 600 种细胞系和约 8000 个肿瘤样本,使用权重来强调已知的致癌改变。我们使用多种数据类型来描述癌症内和癌症间细胞系和肿瘤的相似性,并根据推断出的代表性模型质量对细胞系进行排名。除了对细胞系的评估之外,加权相似性方法还适用于临床试验和个性化医学中的患者分层。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39a5/9017219/c6768c259871/fx1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验